Candel Therapeutics Inc.

NASDAQ: CADL · Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT

Candel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
102.65M 35.41M 70.06M 82.64M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 266K 424K
Other Long-Term Assets
329K 382K 266K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.15M 1.38M 1.89M 2.3M
Total Current Assets
103.8M 36.8M 71.94M 84.94M
Property-Plant & Equipment
2.73M 4.02M 5.48M 3.84M
Goodwill & Intangibles
n/a n/a -1.09M n/a
Total Long-Term Assets
3.06M 4.4M 5.75M 4.26M
Total Assets
106.87M 41.2M 77.69M 89.2M
Account Payables
237K 422K 380K 1.59M
Deferred Revenue
n/a n/a 144K n/a
Short-Term Debt
10.46M 8.89M 464K n/a
Other Current Liabilities
26.83M 2.34M 1.66M 1.68M
Total Current Liabilities
37.53M 14.18M 5.62M 5.36M
Long-Term Debt
2.6M 12.38M 20.85M 560K
Other Long-Term Liabilities
n/a 916K 1.88M 19.15M
Total Long-Term Liabilities
3.01M 14.27M 24.36M 19.71M
Total Liabilities
40.54M 28.46M 29.98M 25.07M
Total Debt
13.47M 22.76M 22.8M 560K
Common Stock
469K 290K 290K 286K
Retained Earnings
-192.21M -137.03M -99.09M -80.3M
Comprehensive Income
n/a n/a -0.00 -89.2M
Shareholders Equity
66.33M 12.74M -99.09M 64.14M
Total Investments
n/a 266K 266K 424K